Author： Iwashima Satoru
Publisher： Adis International
ISSN： 1173-2563
Source： Clinical Drug Investigation, Vol.27, Iss.10, 2007-01, pp. : 691-696
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Pharmacological Therapy for Patients with Kawasaki Disease
By Williams R.V. Minich L.L. Tani L.Y.
Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. :
Access to resources
Recommend
Epidemiology and Management of Kawasaki Disease
By Luca Nadia J.C. Yeung Rae S.M.
Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. :
Overview of Pharmacological Treatment of Kawasaki Disease
By Onouchi Z.
Drugs, Vol. 58, Iss. 5, 1999-11 ,pp. :
New Perspectives in the Drug Treatment of Kawasaki Disease
Pediatric Drugs, Vol. 1, Iss. 4, 1999-10 ,pp. :
Warfarin withdrawal: Arterial thrombosis in a patient with Kawasaki disease: case report
Reactions Weekly, Vol. 1, Iss. 1244, 2009-01 ,pp. :